Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1284 clinical trials
EFFECTIVENESS SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19

This study is clinical trial (intervention study with external comparison group) to test vaccination with reduced dose (half dose) of ChAdOx1 nCoV-19 (AZD1222), in a 2-dose schedule with an

Accepts healthy volunteers
  • 6 views
  • 06 Oct, 2021
  • 1 location
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet

pneumococcal conjugate vaccine
tetanus
ofatumumab
  • 489 views
  • 19 Jun, 2022
  • 127 locations
Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age

adults through active vaccination.

Accepts healthy volunteers
  • 16 views
  • 19 Jun, 2022
  • 28 locations
Immunocompromised Swiss Cohorts Based Trial Platform (COVERALL)

(observational study) is to collect a blood sample before the third vaccination and 8 weeks after vaccination to analyze an additional benefit of a third SARS-CoV-2 vaccine in these immunocompromised patients

  • 0 views
  • 21 Mar, 2022
  • 4 locations
Increase Vaccine Uptake in Adolescent in Rural South (INVEST)

(US) remain under-vaccinated, with vaccination rates among rural adolescents significantly lower than among their urban peers. In addition, there are urban-rural disparities in the coverage of HPV

Accepts healthy volunteers
  • 0 views
  • 25 Mar, 2022
  • 2 locations
A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19

conditions. Study details include: The study duration per participant will be approximately 209 days (28 days screening, 1 day vaccination, and 180 days follow-up). The treatment will

Accepts healthy volunteers
  • 0 views
  • 27 Apr, 2022
  • 4 locations
Testing for COVID-19 in High Risk Children With Intellectual and Developmental Disabilities (COV-IDD)

the school alter chances of infection? Are there people infected with the COVID-19 virus who have no symptoms? How is spread of COVID-19 affected by vaccination rates? Is there any hesitancy to get

  • 0 views
  • 22 May, 2021
  • 1 location
A Trial to Assess the Safety, Immunogenicity and Efficacy of a Trivalent Rotavirus P2-VP8 Subunit Vaccine in Prevention of Severe Rotavirus Gastroenteritis in Healthy Infants in Africa and India

(GE) will be conducted throughout the study, through weekly contact with participants' parents. Unsolicited AEs grade 2 through 28 days after the last study vaccination will be recorded in the study

Accepts healthy volunteers
  • 0 views
  • 15 Feb, 2022
  • 1 location
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

vaccine formulations and the 2 licensed MenB comparator vaccines after the last dose of primary vaccination in healthy adults, adolescents, toddlers and infants, when administered alone, or concomitantly

Accepts healthy volunteers
  • 45 views
  • 29 May, 2022
  • 19 locations
Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants

vaccine formulations and the 2 licensed MenB comparator vaccines after the last dose of primary vaccination in healthy adults, adolescents, toddlers and infants, when administered alone, or concomitantly

Accepts healthy volunteers
  • 29 views
  • 20 May, 2022
  • 21 locations